• Investment supports growing demand for biopharmaceutical manufacturing in China • Accelerates Mobius® single-use manufacturing to bolster novel drug development Wuxi, China – Merck, a leading science and technology company, today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China. This investment follows a year after Merck announced its €80m Life Science investment in Nantong, […]
DARMSTADT, GERMANY Investment supports growing demand for biopharmaceutical research Builds capabilities with two new manufacturing and distribution centers in South Korea and India Accelerates Mobius® single-use manufacturing in China for biosimilars development Darmstadt, Germany – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced an additional investment of $47 million to build a robust […]
Strand Life Sciences announced an investment by Quadria Capital, Asia’s leading healthcare focused private equity investor. India-based HealthQuad Fund and Singapore-based Heritas Venture Fund also contributed to this fund. Strand Life Sciences, formed from the business combination of Strand and Triesta, the diagnostics unit of HCG, is India’s leading specialized diagnostics company. Its expertise spans […]
Funding will help develop new treatments for the commonest cause of chronic liver disease Eagle Genomics and the Stratified Medicine Scotland Innovation Centre (SMS-IC) have been awarded a £1.7M collaborative grant from Innovate UK (the UK’s innovation agency), for a ground-breaking project that could help develop new tests and treatments for patients with non-alcoholic fatty […]
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will make additional investments totaling $50 million as a result of the benefit of recently enacted Federal tax reform legislation in the U.S. This investment includes: $34 million for a one-time bonus of $500 to be paid to each of the company’s approximately 68,000 eligible non-executive employees […]
CAMBRIDGE, UK – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, announced today that it has completed a $12.3 million (£9 million) financing to advance the development of its technology. The financing was co-led by DCVC (Data Collective) of Palo Alto, CA and European-based Draper Esprit, and included […]
Development and Marketing Agreement with TheraCann International Will Create the First Seed-to-Sale Cannabis Tracking System Combining Molecular Tagging and Blockchain Technologies STONY BROOK N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN, “Applied DNA,” “the Company”) today announced the signing of an initial two-year, $1 million contract with TheraCann International Benchmark Corporation, (“TheraCann”), a leading full service cannabis consultancy […]
CAMBRIDGE, Mass–Ultivue, a venture-backed company developing reagent-driven solutions for high-performance biological imaging in situ, has announced today that it has closed a $20 million Series B funding round led by existing investor ARCH Venture Partners. New participating investors accounted for approximately half of the investment and included 6 Dimensions Capital, a recent merger of WuXi […]
Company awarded second patent for CellRaft™ technology RESEARCH TRIANGLE PARK, N.C.–Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced today it has been awarded a $1.5 million grant under the National Institutes of Health (NIH) SBIR program. The proposed system integrates Cell Microsystems’ proprietary CellRaft Technology […]
Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization. SALT LAKE CITY Carterra Inc., an innovative label-free biosensor company, has announced the closing of a $10M financing from Telegraph Hill Partners (THP). The proceeds will be used to complete development and commercialize the Company’s LSA™ instrument, a fully automated, high-throughput […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
